EE526 Public Health Impact and Cost-Effectiveness of Recombinant Zoster Vaccine for Vaccinating Immunocompromised Adults Against Herpes Zoster in the United States
Abstract
Authors
A Salem D Curran J Carrico EM La S Lorenc K Hicks S Poston CF Carpenter